Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
BMC Medicine|March 1, 2021
Optimizing antiviral treatment for seasonal influenza in the USA: a mathematical modeling analysisMatan Yechezkel, Martial L Ndeffo Mbah, Dan YaminScientific Reports|April 6, 2024
Utilizing direct and indirect information to improve the COVID-19 vaccination booster schedulingYotam Dery, Matan Yechezkel, Irad Ben-Gal, et al.Cell Reports. Medicine|April 26, 2021
BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in IsraelAriel Munitz, Matan Yechezkel, Yoav Dickstein, et al.Communications Medicine|April 17, 2023
Real-time sensing of war's effects on wellbeing with smartphones and smartwatchesMerav Mofaz, Matan Yechezkel, Haim Einat, et al.BMC Public Health|March 26, 2021
Human mobility and poverty as key drivers of COVID-19 transmission and controlMatan Yechezkel, Amit Weiss, Idan Rejwan, et al.Plos One|July 20, 2021
Early detection of COVID-19 outbreaks using human mobility dataGrace Guan, Yotam Dery, Matan Yechezkel, et al.Scientific Reports|May 12, 2026
Enhancing randomized controlled trials through smartwatch-guided participant matching for infectious disease outcomesEdan Shahmoon, Matan Yechezkel, Shachar Snir, et al.The Lancet. Respiratory Medicine|November 21, 2022
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort studyMatan Yechezkel, Merav Mofaz, Amichai Painsky, et al.The Lancet Regional Health. Europe|May 27, 2024
Changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS): a two-year prospective cohort study in IsraelShachar Snir, Yupeng Chen, Matan Yechezkel, et al.Communications Medicine|August 24, 2024
Comparison of physiological and clinical reactions to COVID-19 and influenza vaccinationMatan Yechezkel, Gary Qian, Yosi Levi, et al.Pageof 3